Relay Therapeutics (RLAY) Short Interest Ratio & Short Volume $8.94 -0.12 (-1.32%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Relay Therapeutics Short Interest DataCurrent Short Interest8,430,000 sharesPrevious Short Interest8,050,000 sharesChange Vs. Previous Month+4.72%Dollar Volume Sold Short$69.72 millionShort Interest Ratio6.2 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares132,740,000 sharesPercentage of Shares Shorted6.35%Today's Trading Volume830,459 sharesAverage Trading Volume1,384,465 sharesToday's Volume Vs. Average60% Short Selling Relay Therapeutics ? Sign up to receive the latest short interest report for Relay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLAY Short Interest Over TimeRLAY Days to Cover Over TimeRLAY Percentage of Float Shorted Over Time Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. Relay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20248,430,000 shares $69.72 million +4.7%N/A6.2 $8.27 6/30/20248,050,000 shares $52.49 million -18.3%N/A6.1 $6.52 6/15/20249,850,000 shares $72.00 million +2.6%N/A7.5 $7.31 5/31/20249,600,000 shares $61.54 million -19.3%N/A7.3 $6.41 5/15/202411,890,000 shares $80.79 million +3.1%N/A9.5 $6.80 4/30/202411,530,000 shares $75.18 million +7.9%N/A9.4 $6.52 Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/202410,690,000 shares $73.01 million -4.3%N/A9 $6.83 3/31/202411,170,000 shares $92.71 million -5.4%N/A10 $8.30 3/15/202411,810,000 shares $93.89 million +7.4%N/A10.9 $7.95 2/29/202411,000,000 shares $110.22 million +12.1%N/A10.5 $10.02 2/15/20249,810,000 shares $104.67 million +3.8%N/A9.2 $10.67 1/31/20249,450,000 shares $87.41 million -16.3%11.0%9.5 $9.25 1/15/202411,290,000 shares $124.19 million -6.0%13.1%10.3 $11.00 12/31/202312,010,000 shares $132.23 million -12.3%14.1%10.4 $11.01 12/15/202313,700,000 shares $138.92 million -6.4%16.1%11.5 $10.14 11/30/202314,630,000 shares $115.72 million -0.1%17.3%12.1 $7.91 11/15/202314,640,000 shares $125.17 million +1.5%17.3%12.7 $8.55 10/31/202314,430,000 shares $95.24 million +4.8%16.9%12.9 $6.60 10/15/202313,770,000 shares $106.58 million -29.0%16.3%13.5 $7.74 9/30/202319,400,000 shares $163.15 million -3.4%22.9%19.9 $8.41 9/15/202320,080,000 shares $188.15 million +1.0%23.7%21 $9.37 8/31/202319,890,000 shares $203.28 million -3.9%23.5%19.1 $10.22 8/15/202320,700,000 shares $219.83 million +5.5%24.5%18.3 $10.62 7/31/202319,630,000 shares $247.34 million -1.1%23.3%16.4 $12.60 7/15/202319,840,000 shares $242.64 million -3.1%23.8%14.7 $12.23 6/30/202320,480,000 shares $257.23 million -2.9%24.6%12.1 $12.56 6/15/202321,080,000 shares $269.61 million -0.4%25.3%12.3 $12.79 5/31/202321,160,000 shares $235.72 million -1.5%25.4%13.1 $11.14 5/15/202321,480,000 shares $221.03 million +8.5%25.8%13.6 $10.29 4/30/202319,800,000 shares $225.13 million +1.4%23.4%13 $11.37 4/15/202319,530,000 shares $340.60 million +3.3%23.1%13.3 $17.44 3/31/202318,910,000 shares $311.45 million +5.5%22.4%15.4 $16.47 3/15/202317,930,000 shares $295.85 million +0.8%21.3%13.8 $16.50 2/28/202317,780,000 shares $287.15 million +3.0%21.1%13 $16.15 2/15/202317,270,000 shares $317.25 million -0.6%20.6%12.9 $18.37 1/31/202317,380,000 shares $372.97 million -6.9%20.7%13 $21.46 1/15/202318,660,000 shares $387.57 million +10.5%22.2%14.7 $20.77 12/30/202216,890,000 shares $252.34 million +25.8%20.0%13.8 $14.94 12/15/202213,430,000 shares $230.59 million +7.5%15.9%12.2 $17.17 11/30/202212,490,000 shares $232.06 million -4.3%14.8%11.1 $18.58Top Stock Unveiled! (Ad)Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report 11/15/202213,050,000 shares $258.39 million -3.1%15.4%10.5 $19.80 10/31/202213,460,000 shares $299.08 million +3.1%16.5%10.9 $22.22 10/15/202213,060,000 shares $254.80 million +7.2%16.1%10.4 $19.51 9/30/202212,180,000 shares $272.47 million +4.0%15.0%10.2 $22.37 9/15/202211,710,000 shares $293.69 million -25.0%15.9%9.2 $25.08 8/31/202215,620,000 shares $358.79 million -15.2%21.2%13.4 $22.97 8/15/202218,420,000 shares $386.27 million -1.8%25.1%18.1 $20.97 7/31/202218,760,000 shares $356.82 million -1.4%25.6%17.4 $19.02 7/15/202219,020,000 shares $368.99 million -6.8%26.0%17.9 $19.40 6/30/202220,410,000 shares $341.87 million +11.2%27.9%20.2 $16.75 6/15/202218,360,000 shares $263.10 million +2.5%25.1%19.2 $14.33 5/31/202217,920,000 shares $291.74 million +9.6%24.5%23.3 $16.28 5/15/202216,350,000 shares $287.43 million +11.7%22.3%21.9 $17.58 4/30/202214,640,000 shares $348.87 million +2.0%19.9%22.2 $23.83 4/15/202214,360,000 shares $441.43 million -1.8%19.6%22.8 $30.74 3/31/202214,620,000 shares $437.58 million -8.9%19.9%22.6 $29.93 3/15/202216,050,000 shares $367.87 million +4.4%21.9%26.4 $22.92 2/28/202215,380,000 shares $370.81 million +2.1%21.0%26.1 $24.11 2/15/202215,070,000 shares $323.25 million +1.3%21.6%25.1 $21.45 1/31/202214,880,000 shares $329.29 million +7.5%21.1%26.3 $22.13 1/15/202213,840,000 shares $363.85 million +1.1%22.2%25.8 $26.29 12/31/202113,690,000 shares $420.42 million -3.9%21.9%19 $30.71 12/15/202114,250,000 shares $414.11 million +3.3%22.8%17.7 $29.06 11/30/202113,790,000 shares $405.70 million +2.6%22.3%16.5 $29.42 11/15/202113,440,000 shares $474.70 million +6.6%21.8%15.8 $35.32 10/29/202112,610,000 shares $419.28 million -1.3%22.5%14.5 $33.25 10/15/202112,770,000 shares $435.58 million +21.0%22.8%15.3 $34.11 9/30/202110,550,000 shares $332.64 million +5.5%18.8%16.8 $31.53 9/15/202110,000,000 shares $369.30 million -3.3%17.8%17.8 $36.93 8/31/202110,340,000 shares $331.19 million -1.0%18.5%20 $32.03 8/13/202110,440,000 shares $344.83 million +6.1%18.7%21 $33.03 7/30/20219,840,000 shares $319.21 million +7.3%18.8%21 $32.44 7/15/20219,170,000 shares $292.16 million +2.2%17.2%17.4 $31.86 6/30/20218,970,000 shares $328.21 million +7.0%17.1%16.3 $36.59 6/15/20218,380,000 shares $287.10 million -3.6%15.9%14.6 $34.26 5/28/20218,690,000 shares $279.12 million +4.1%16.5%13.5 $32.12 5/14/20218,350,000 shares $229.63 million +0.2%15.9%12.3 $27.50 4/30/20218,330,000 shares $277.39 million +10.0%18.5%11.5 $33.30 4/15/20217,570,000 shares $257.76 million -7.5%16.8%11.2 $34.05 3/31/20218,180,000 shares $291.04 million +23.2%18.2%10.2 $35.58 3/15/20216,640,000 shares $260.89 million +4.1%14.8%8.7 $39.29 2/26/20216,380,000 shares $270.00 million +20.2%14.3%9.9 $42.32 2/12/20215,310,000 shares $245.48 million -2.9%11.9%9 $46.23 1/29/20215,470,000 shares $291.00 million -18.6%12.1%10.4 $53.20 1/15/20216,720,000 shares $294.13 million No Change14.9%13.8 $43.77 RLAY Short Interest - Frequently Asked Questions What is Relay Therapeutics' current short interest? Short interest is the volume of Relay Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 8,430,000 shares of RLAY short. Learn More on Relay Therapeutics' current short interest. What is a good short interest ratio for Relay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLAY shares currently have a short interest ratio of 6.0. Learn More on Relay Therapeutics's short interest ratio. Is Relay Therapeutics' short interest increasing or decreasing? Relay Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 8,430,000 shares, an increase of 4.7% from the previous total of 8,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relay Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Relay Therapeutics: Vir Biotechnology, Inc. (5.32%), Allogene Therapeutics, Inc. (31.63%), Fate Therapeutics, Inc. (17.82%), Apellis Pharmaceuticals, Inc. (12.50%), Avidity Biosciences, Inc. (13.50%), Crinetics Pharmaceuticals, Inc. (8.34%), Immunovant, Inc. (16.45%), Arcellx, Inc. (12.47%), Xenon Pharmaceuticals Inc. (4.33%), Merus (12.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Relay Therapeutics stock? Short selling RLAY is an investing strategy that aims to generate trading profit from Relay Therapeutics as its price is falling. RLAY shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relay Therapeutics? A short squeeze for Relay Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLAY, which in turn drives the price of the stock up even further. How often is Relay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLAY, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VIR Short Squeeze ALLO Short Squeeze FATE Short Squeeze APLS Short Squeeze RNA Short Squeeze CRNX Short Squeeze IMVT Short Squeeze ACLX Short Squeeze XENE Short Squeeze MRUS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLAY) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.